Formulations And Treatments For Trichology

Abstract

a formulation for trichological treatment of a patient including, in a dosage in the range of 3 g to 8 g: phytosterols in the range of 200 mg to 2500 mg; the quantitative equivalent of Polygonum multiflorum root 4:1 in 70% EW in the range of 600 mg to 2600 mg; methylsulfonylmethane in the range of 500 mg to 2000 mg; and bovine colostrum in the range of 500 m to 2000 m.

Description

FIELD OF INVENTION[0001]THIS INVENTION relates to formulations and treatments for trichology. The invention is primarily directed to formulations and treatments for reduction of hair loss and / or hair regrowth typically exhibited in adult humans having a condition sometimes referred to alopecia. Although the condition is more prevalent in human males and is sometimes referred to as male pattern alopecia, the invention is applicable to treatment of both male and female alopecia.BACKGROUND ART[0002]Herbal extracts and formulations have been suggested for the trichological treatment of humans, particularly males, but not exclusively so. Efficacy varies from nil to some reduction in hair loss and / or noticeable hair regrowth on the heads of patients. However, the interaction of the constituent compounds in such formulations with one another is little understood. The respective modes of action of such formulations are quite diverse. Generally, such treatments are either topical or systemic...

AI Technical Summary

Benefits of technology

[0090]preparing a predetermined quantity of a second formulation for topical application, the second formulation consisting of: a hair growth component for promoting the anagenic phase of hair growth and / or minimising the catagenic and / or telegenic phases of hair growth; a hair growth component complement for complementing the functional qualities of the hair growth component; a metabolism-balancing component for balancing the metabolism of the patient; a 5-alpha reductase production inhibitor for inhibiting the patient's production of 5-alpha reductase; an amino acid complement providing substantially all of the amino acids required for metabolism of the patient; a nitric oxide metabolite from which nitric oxide may be produced in the metabolic processes of the patient; a keratinocyte cell supplement for supplementing nutrients for the patient's keratinocyte cells; a carbohydrate metabolism facilitator for facilitating carbohydrate metabolism of the patient; a hair cortex elasticity component for enhancing the elasticity of the hair cortices of the patient; an enzymatic antioxidant and detoxifying component for detoxifying the patient, including the scavenging of oxidants; a mineral anti-oxidant component for supplementing the enzymatic antioxidant and detoxifying component; and an immunoglobulin and growth-factor supplement for supplementing the patient's intake of immunoglobulin and growth factor.

Problems solved by technology

However, the interaction of the constituent compounds in such formulations with one another is little understood.

Other root causes are not well understood and / or subject of conjecture.

There is a quantity of research data on efficacy, some of which is in conflict, indicating that the alopecia condition is complex, and is probably affected by a range of different mechanisms.

Some root causes are expressed or exhibited more than others, but unless several of such root causes are addressed by a proposed remedy, it is suggested that its efficacy may be limited.